Active treatment in high-risk, early-stage CLL or SLL.
Year: 2026
Type: other
Source: PubMed
Author: Deborah M Stephens
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7164614221
